not entitled for exchange:CM (N/A)

Overview Price 0.00 Price Change Today 0.00 (0.00%) P&P rating Zacks Rank N/A - N/A Open Price $0.00 Previous Close $0.00 Daily Range $0.00 - $0.00 52-Week Range $0.00 - $0.00 Volume 0 Valeant Pharmaceuticals International, Inc. is a pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. The Company produces medicines that meet the special health problems of patients. Valeant's development pipeline strategy comprises both new compounds as well as product life cycle management. Its early and late-stage drug candidates have unique formulations and mechanisms of action including retigabine for the treatment of epilepsy and pain, taribavirin of the treatment of chronic hepatitis C, and several dermatology candidates for the treatment of rosacea, acne, and dermatological fungus. Valeant Pharmaceuticals International, Inc. is headquartered in Mississauga, Canada. Other Resources for N/A Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary No Commentary Found for This Ticker.   No brokerage coverage for N/A No Data Available

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 0 Buy 0 Sell   Top Buy Analysis No Buy Analysis. Be the First. More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
PandPBlog	0.00	09/08/10	The P&P Podcast, Episode 2	0
Zacks_Analysts	0.00	08/31/10	New Action Date for Epilepsy Drug - Analyst Blog	0
Zacks_Analysts	0.00	08/13/10	Biovail Beats in Q2 - Analyst Blog	0
Zacks_Analysts	0.00	08/12/10	FDA Panel Backs Anti-Epileptic Drug - Analyst Blog	0
Zacks_Analysts	0.00	08/05/10	Valeant Pharma Beats, Ups Guidance - Analyst Blog	0
Zacks_Analysts	0.00	06/22/10	Biovail and Valeant to Merge - Analyst Blog	0
Zacks_Analysts	0.00	03/10/10	3 Chances with Pimavanserin - Analyst Blog	0
Zacks_Analysts	0.00	10/14/09	Biovail Continues with Pimavanserin - Analyst Blog	0
Zacks_Analysts	0.00	08/24/09	Biovail to develop Parkinson Drug - Analyst Blog	0

Pages: [ 1 ]  2  >>

Commentary

There are no open picks with this stock at the moment.

Picks

There are no open picks with this stock at the moment.